Abstract
Implantable cardioverter–defibrillators (ICD) have to reliably sense, detect, and treat malignant ventricular tachyarrhythmias. Inappropriate treatment of non life-threatening tachyarrhythmias should be avoided. This article outlines the functionality of ICDs developed and manufactured by BIOTRONIK. Proper sensing is achieved by an automatic sensitivity control which can be individually tailored to solve special under- and oversensing situations. The programming of detection zones for ventricular fibrillation (VF), ventricular tachycardia (VT), and zones to monitor other tachyarrhythmias is outlined. Dedicated single-chamber detection algorithms based on average heart rate, cycle length variability, sudden rate onset, and changes in QRS morphology as used in ICDs by BIOTRONIK are described in detail. Preconditions and confirmation algorithms for therapy deliveries as antitachycardia pacing (ATP) and high energy shocks are explained. Finally, a detailed description of the dual-chamber detection algorithm SMART is given. It comprises additional detection criteria as stability of atrial intervals, 1:1 conduction, atrial–ventricular (AV) multiplicity, AV trend, and AV regularity to differentiate between ventricular and supraventricular tachyarrhythmias.
Zusammenfassung
Ein implantierbarer Kardioverter-Defibrillator (ICD) muss in der Lage sein, maligne ventrikuläre Tachyarrhythmien zuverlässig zu erkennen, zu klassifizieren und zu behandeln. Eine unangebrachte Therapieabgabe bei nicht lebensbedrohlichen Tachyarrhythmien sollte vermieden werden. Im Rahmen dieses Artikels soll die Funktionsweise von ICDs der Firma BIOTRONIK dargelegt werden. Eine korrekte Erkennung von Herzaktionen wird durch eine automatische Wahrnehmungsfunktion erreicht, die auch die Möglichkeit einer individuellen Anpassung bietet, um spezielle Wahrnehmungsprobleme (z. B. Over- und Undersensing) zu lösen. Die Programmierung von Detektionszonen für die Erkennung von Kammerflimmern, Kammertachykardien und zur Überwachung anderer Tachyarrhythmien wird besprochen. Dezidierte 1‑Kammer-Detektionsalgorithmen, wie sie in ICDs der Fa. BIOTRONIK verwendet werden, basieren auf der gemittelten Kammerfrequenz, der Variabilität der Kammerzykluslängen, dem Vorliegen eines plötzlichen Anstiegs der Herzfrequenz und auf Veränderungen der QRS-Morphologie. Weiterhin werden Vorbedingungen und Bestätigungsalgorithmen für die Abgabe einer antitachykarden Stimulation bzw. eines hochenergetischen Schocks erläutert. Schließlich wird eine detaillierte Beschreibung des 2‑Kammer Detektionsalgorithmus SMART von BIOTRONIK gegeben. Hier werden zusätzliche Detektionskriterien wie die Vorhoffrequenz, die Variabilität der Vorhofzykluslängen, 1:1-AV/VA-Überleitung, atrioventrikuläre (AV) Multiplizität, AV-Trend sowie die Regelmäßigkeit der AV-Überleitung verwendet, um zuverlässig zwischen ventrikulären und supraventrikulären Tachyarrhythmien zu unterscheiden.
Similar content being viewed by others
Introduction
The detection of cardiac arrhythmias and their differential diagnosis by using automatic algorithms built in implantable cardioverter–defibrillators (ICD) is one of the most critical issues in patients with an ICD. The main goal of these detection algorithms is to provide 100 % sensitivity to recognize potentially life-threatening ventricular tachyarrhythmias in order to avoid untreated episodes of malignant ventricular tachycardia (VT) or ventricular fibrillation (VF). On the other hand, these detection algorithms are expected to provide the highest possible specificity in order to avoid inappropriate ICD therapies. The following article tries to explain the functionality, means, possibilities, and restrictions of sensing and discrimination algorithms used in ICDs from BIOTRONIK.
Sensing
Automatic sensitivity control
ICDs cannot use static sensing thresholds because the amplitude of intracardiac signals varies with different cardiac rhythms. Therefore, BIOTRONIK ICDs utilize automatic sensitivity control to automatically adjust the atrial and ventricular sensing thresholds. The input stage has a low-pass and a high-pass filter and two threshold levels, which are set in relation to the signal peak amplitude for predefined time periods. Then the threshold will further decay over time to a preset minimal sensing threshold. Special presettings are available for T‑wave oversensing and for a higher VF sensitivity. Modification of all sensing parameters (e.g., filter characteristics, threshold levels, holding periods, blanking periods, refractory periods) is possible with support from an experienced BIOTRONIK employee in case of unusual signals or in special troubleshooting situations.
Ventricular sensitivity
Standard settings
In the standard setting, the sensing stage is blanked for 110 ms after each sensed R‑wave. Each R‑wave is measured and used to set the upper and lower thresholds. The upper threshold after sensing is set to 50 % of the peak R‑wave amplitude. Following the upper threshold duration of 350 ms (after sensing), the device sets the lower threshold to 25 % of the measured R‑wave for 156 ms. The device will continue to decrement the actual sensing threshold by 12.5 % every 156 ms until either the minimum threshold is reached or a new R‑wave occurs (Fig. 1). The right ventricular minimum threshold is nominally at 0.8 mV and programmable from 0.5 to 2.5 mV. The upper threshold duration after sensing may be extended, e. g., in patients with long QT syndrome or T‑wave oversensing.
Automatic sensitivity control behaves slightly differently after a paced event. At the end of a blanking period of 120 ms, the ventricular sensing threshold will be at 50 % of the measured amplitude until 400 ms after pace has expired. Then the sensing threshold will drop to 25 % of the event amplitude followed by further decrementation as described above (Fig. 2). Alternatively, the sensing threshold start value at the end of the blanking period can be also programmed to a fixed sensing threshold value (3 mV by default). This feature may be used when the patient has small amplitude R‑waves (<4 mV) or large T‑waves in particular after ventricular pacing.
Enhanced T‑wave suppression
The characteristics of the automatic sensitivity control can be modified for troubleshooting purposes in case of ventricular oversensing due to large repolarization signals as T‑waves. Two parameters are automatically changed with programming of enhanced T‑wave suppression (TWS): 1) The high-pass filtering is increased from 24 to 32 Hz to reduce low-frequency signal components such as repolarization signals and respiratory artifacts and 2) the upper threshold is increased to 75 % of the measured R‑wave amplitude (Fig. 3). While TWS can eliminate T‑wave oversensing, the setting should be used with caution if the R‑wave signal amplitude during T‑wave oversensing is low (e. g., less than 4 mV). In general, VF detection should be retested when the sensitivity setting is reprogrammed.
Enhanced VF sensitivity
This feature was specifically designed to improve VF detection when the VF signal is small, which can lead to ventricular undersensing (i. e., signal drop-out) during VF detection. Two adjustments are made to the settings of automatic sensitivity control: 1) the upper threshold duration after sense is decreased to 110 ms (Fig. 4), 2) the high pass filtering is changed from 24 to 32 Hz. Both adjustments ensure that the threshold approaches the minimum threshold more quickly. If undersensing is still present, the minimum threshold may also need to be adjusted. These settings should be also used with caution, as oversensing of the intrinsic complex may occur. Detection of VF should be retested when the sensitivity setting is reprogrammed.
Atrial sensitivity in dual-chamber ICDs and CRT-D devices
The atrial automatic sensitivity control works similar to the ventricular standard settings. Each P-wave is measured and used to define upper and lower atrial sensing thresholds. The upper threshold is set to 50 % of the peak P-wave amplitude and is hold for 350 ms after atrial sensed and paced events. Then the atrial sensing threshold decreases to 25 % and decays 12.5 % every 156 ms until either the minimum atrial threshold is reached or until the next atrial event, sensed or paced, has occurred (Fig. 5).
Postventricular atrial refractory period
Postventricular atrial refractory period (PVARP) is used to prevent pacemaker-mediated endless loop tachycardia (ELT) by not allowing atrial events to be tracked by the device. Please note that programming long PVARP values in combination with long AV delays might result in reduced 1:1 tracking by the device and can increase the risk of retrograde conduction. In some cases a retrograde conduction test can be of help before making any programming changes. Generally, PVARP should be programmed 15–20 ms longer than the measured retrograde conduction time. Programming PVARP too long could result in nontracking of antegrade atrial events. Default settings are 175 ms and 325 ms for PVARP after premature ventricular contraction (PVC). Auto PVARP is an option that will automatically adjust the PVARP value when ELT occurs. The devices have an algorithm to recognize and terminate ELT. Following an ELT, the device will extend PVARP by 50 ms. After seven days of no ELT, the PVARP value will be reduced by 50 ms to a minimum value of 175 ms. PVARP after PVC is a parameter that is used to prevent ELT following PVC events by adding a fixed value of 150 ms to the programmed PVARP for that PVC event. By default, this value is 375 ms; the maximum value is 600 ms.
Far-field protection
This feature is activated in the standard program to prevent oversensing of crosstalk events to avoid inappropriate therapies or mode switching. Far-field protection means that the signals that occur during this time interval are not sensed by the device (i. e., blanking period). As a result, there will be no annotations on the marker channel, and these events are not recorded in the device diagnostics.
Far-field protection after a ventricular-sensed event (Vs) initiates an atrial blanking period before and after each ventricular-sensed event. The blanking period before Vs is fixed to 16 ms, the total duration of this blanking period is programmable (default 75 ms). Far-field protection after ventricular-paced events (Vp) is used to address oversensing in the atrial channel that occurs from ventricular pacing. Atrial blanking periods are identical to those after Vs. It is important to note that while these parameters will prevent oversensing from ventricular sensed/paced events, it will not alter the morphology of intracardiac electrogram (IEGM). In troubleshooting situations it is important to determine the exact duration of the blanking period required to eliminate far-field sensing, as too much blanking can negatively interfere with the capability to detect atrial tachyarrhythmias and the functionality of dual-chamber detection algorithms.
Discrimination after atrial sensing (As)
This feature has been introduced to provide a more accurate classification of premature ventricular contraction (PVC) and event timing. If an RV-sensed event occurs within 350 ms after an atrial refractory-sense event (Ars), the device assumes the Vs event to be a response to the previous atrial (Ars) event (i. e., AV conducted). As a result, the device will consider the Vs event to be an AsVs event, rather than an Ars event followed by a PVC, and will be annotated as such. This will provide a more accurate PVC count and event timing (Fig. 6).
Detection
To ensure that appropriate ICD therapy is delivered, ventricular tachycardia (VT) and ventricular fibrillation (VF) must be distinguished from normal sinus rhythm (SR) and supraventricular tachycardias (SVT). This is accomplished by proper device sensing, as well as appropriate detection. The ICD detects and measures the rate of sensed cardiac signals to discriminate ventricular tachyarrhythmias from SVTs, SR or sinus bradycardia. This is accomplished through programmable rate detection parameters in the device. When a tachyarrhythmia is present, the ICD classifies the arrhythmia and delivers appropriate therapy. In case of a spontaneous termination of the tachyarrhythmia during detection, the counters are reset in case of five consecutive intervals that do not fall into any tachyarrhythmia zone with therapy (so-called “short termination”). If a tachyarrhythmia continues following the first therapy attempt, then the ICD will redetect the tachyarrhythmia and deliver subsequent therapies as necessary.
Ventricular tachyarrhythmia detection
Classification of cardiac signals is accomplished primarily by measuring cardiac cycle lengths (R-R, P‑R, and P‑P). In addition, the ICD can also utilize abrupt changes in rate, irregularity of the cycle lengths and other criteria to further differentiate ventricular tachyarrhythmias. Each detected ventricular tachyarrhythmia is classified into one of the following zones:
-
VT-1 lower rate ventricular tachycardia,
-
VT-2 higher rate ventricular tachycardia, or
-
VF ventricular fibrillation.
Each zone is programmable to a separate rate with the zone limit defining the lowest rate in each zone. The upper rate limit of each zone is equal to the zone limit of the next higher class, creating a continuous range of rate classes.
VF detection
Detection in the VF zone relies on an X out of Y detection criterion. If X intervals within a rolling window of Y intervals are shorter (i. e., the rate is faster) than the VF detection interval/rate limit, then VF is declared as detected (Fig. 7) and VF therapy will be delivered. Recommended combinations are 30 out of 40, 24 out of 30 or shorter combinations (e. g., 18 out of 24). The rate limit should be programmed between 211 bpm and 231 bpm (i. e., the R‑R interval between 284 ms and 260 ms) [1]. VF redetection counters can be programmed differently from initial VF detection criteria in newer generation devices.
Ventricular-only detection for VT
When a VT zone is programmed, the ventricular-only detection algorithm uses a programmable VT interval count and based on a rate/interval cut-off criteria. This means that any time the rhythm crosses the programmed VT detection interval, the ICD will classify the event as VT. VT detection relies on simple up/down counters (i. e., separate for VT1 and VT2 zone), ventricular rate, and single-chamber enhancement. Detection enhancements such as Onset, Stability and MorphMatch can be added to help to discriminate VT from SVT. These detection enhancements are sometimes referred to as “therapy inhibitors”, as both interval count and the programmed detection enhancement criteria must be met to classify an arrhythmia. The VT detection counter determines the minimal number of VT events for each zone that must be counted to initiate VT detection and therapy delivery. The redetection counter of the VT1 zone must be greater than the redetection counter of VT2 zone and the “X” value of the VF zone detection counter.
Rate only.
When Rate Only is used, detection is met when the programmed number of intervals exceed the programmed detection count. Each time an interval is shorter than the programmed VT zone limit, the VT counter increments (+1). Conversely, the VT counters decrement by one (−1) when an interval is longer than the programmed limit for that zone. All intervals in the VT2 zone will also increment the VT1 counter (Fig. 8). Intervals longer than the defined detection zones decrement the counter for that zone.
Stability.
Stability is a detection enhancement to assist in determining if a tachyarrhythmia is VT or atrial fibrillation with a rapid ventricular response. Stability refers to the stability of R‑R intervals. Monomorphic VT demonstrates a stable R‑R interval, while in atrial fibrillation the R‑R intervals are typically unstable. Stability is evaluated on a beat-to-beat basis. Stability is used for detection and redetection. The Stability criterion is satisfied for a given ventricular interval when the difference between the current interval and each of the three preceding intervals is less than the programmed Stability limit. Unstable events reset the VT counters to zero and can potentially delay therapy. Programming a higher value of stability (i. e., allowing less stable intervals to be classified stable) can result in therapy delivery for atrial fibrillation, while programming a lower value may result in inhibition of therapy for VTs which may be slightly unstable (Fig. 9). The recommended default setting for single-chamber ICDs is 40 ms or 12 % for newer generation ICDs [1].
Sudden onset.
Sudden Onset is a detection enhancement that can help to determine whether a tachyarrhythmia is of ventricular or supraventricular origin. Spontaneous VTs typically demonstrate a sudden increase in ventricular rate, while sinus tachycardias increase the ventricular rate slowly over time (Fig. 10). Sudden onset is programmed to a default value of 20 % and is available in both VT1 and VT2 zones. This Onset algorithm is designed in order to prevent single fast events as extra beats to fulfill Onset and potentially lead to inappropriate therapy. Onset applies to the ventricular chamber only. Once Onset is fulfilled, it is declared for the entire episode, including redetection. It can be reset by five consecutive intervals that are out of any VT/VF zones with therapy.
Morphology.
An additional detection enhancement based on changes in the QRS morphology is available when using ventricular-only detection for VT. The QRS morphology is analyzed in a 250 ms window around the peak of QRS in the far-field EGM. This MorphMatch algorithm is based on beat-to-beat analysis of the QRS peak amplitude, the QRS area, and four major QRS deflections. The difference to the reference is calculated for every single beat after alignment of the actual beat to the reference QRS. Normal beats continuously update the reference QRS and an average variability of normal beats is calculated. This average variability (i. e., mean difference to the reference) plus a programmable safety margin result in a morphology threshold to declare a QRS complex as abnormal (e. g., VT) or normal (e. g., SVT) (Fig. 11). The MorphMatch criterion can be programmed active or inactive.
In parallel to the VT counter a MorphMatch counter increments if the QRS morphology is classified as abnormal. With MorphMatch active an episode is declared as VT when the VT detection count is met, stability and onset are fulfilled, and at least 50 % of the QRS complexes have an abnormal morphology according to MorphMatch. If less than 50 % of the QRS complexes have an abnormal morphology according to MorphMatch this episode is declared as SVT (Fig. 12).
Detection criteria associated with therapy delivery
ATP one-shot.
ATP One-shot is a feature that delivers a single ATP therapy for a stable rhythm in the VF zone prior to shock charging. The rhythm in the VF zone must be regular (i. e., within 12 % stability), such as a stable fast monomorphic VT. There is no rate limit for ATP One-shot. Once the ATP is delivered, charging of the capacitors begins automatically. During charging, the device continues to classify the rhythm and charging is aborted once three long intervals (out of four) occur (Fig. 13). ATP One-shot is automatically disabled after four consecutive unsuccessful attempts. When the device is interrogated, ATP One-shot will automatically re-enabled. After analyzing the episodes, the user can decide to deactivate this therapy option.
Shocks with confirmation (“non-committed shocks”).
Rhythm classification continues through the charging period when shock confirmation is programmed to ON. If the device detects during charge three out of four slow events (i. e., sinus or paced), then the device aborts shock therapy (Fig. 14). If self-termination occurs or no further VT/VF intervals are available to synchronize the shock, then the shock delivery will be withheld. The device then begins the redetection/termination process. The aborted shock energy is slowly released into an internal resistor and may make up to 10 min to bleed off. If charging ends, a 70 ms blanking interval is started to avoid oversensing of artefacts due to the switch of high voltage. The shock energy is delivered 30 ms after the next VT/VF interval (Fig. 15).
Confirmation applies to all shocks within the programmed VT or VF zone. With confirmation programmed ON, the first shock in the detected ventricular tachyarrhythmia zone is non-committed. Each time a shock is aborted, the next shock after redetection is automatically committed. The device will not allow two aborted shocks in a row to occur. This is a safety feature, should intermittent undersensing of a ventricular tachyarrhythmia be present, to prevent therapy inhibition.
Shocks without confirmation (“committed shocks”).
A committed shock is a shock delivered after (re-)detection and charge. There is no attempt to recheck or verify the rhythm prior to shock delivery. The device tries to synchronize with the first ventricular sensed or paced event (Fig. 16). However, if synchronization is not possible, the device delivers the shock asynchronously within two seconds.
Detection of the end of episode (termination detection).
Termination of a ventricular tachyarrhythmia episode is based on a nonprogrammable 12 out of 16 termination criterion. Termination of an episode is declared when twelve out of a sliding window of 16 intervals are longer (i. e., the rate is slower) than the lowest programmed cutoff interval/rate limit with therapy. This includes also postshock and antibradycardia pacing intervals. If 12 long intervals are measured before the first window of 16 intervals, termination is declared with the twelfth interval (Fig. 13). If detection starts anew following termination, all programmed therapy is available for treatment.
Criteria used for dual-chamber AV discrimination (SMART)
When the SMART algorithm for dual-chamber detection is active, information from the atrial and ventricular chambers of the heart is used for VT classification. The algorithm is specifically designed to detect VT while withholding therapy upon detection of an SVT. The algorithm performs classification on a beat-to-beat basis. Classification begins after the cycle length is measured and determined to lie within the programmed VT zones. Thereafter, a series of tests is performed to determine if the arrhythmia is atrial or ventricular in origin. SMART detection is programmed ON by default in dual-chamber and CRT-ICDs when a VT zone is programmed. It is not available in the VF zone.
Rate (interval)
SMART Detection uses a sliding average of atrial and ventricular intervals to compare the overall atrial and ventricular rates (Fig. 17). This is used to determine whether the rates in the atrium and in the ventricle differ from each other. This is the first criterion of the SMART Detection algorithm.
Stability
With SMART Detection on, stability is checked on a beat-to-beat basis in the atrium and the ventricle (Fig. 18). Although the calculation of stability is determined independently in both chambers, the same default of 12 % is used for each chamber.
Sudden onset
Sudden Onset is used in the SMART Detection algorithm when the atrial and ventricular rhythms are stable and equal in rate to distinguish VT from slow onset sinus tachycardia. Sudden Onset is applied in the ventricular chamber only and programmed at 20 % by default (Fig. 10).
AV trend
SMART Detection measures the AV trend to determine whether a consistent pattern between the atrial and ventricular rhythms (AV association) exists. This is performed when the atrial and ventricular rates are stable and equal. With each new ventricular interval, the algorithm checks to see whether the four most recently measured AV intervals are in strict increasing or decreasing order (Fig. 19). This strict order of AV intervals defines a consistent trend towards AV shortening or AV prolongation that is indicative of AV dissociation.
AV regularity
SMART Detection measures AV regularity to determine whether a consistent pattern between the atrial and ventricular rhythms is present. The device compares the current AV interval against the three previous AV intervals without averaging. An AV interval is determined to be regular if the interval does not differ from the three preceding AV intervals by more than the AV limit. The AV limit is a predetermined value equal to half of the stability limit, or 6 %, by default.
AV multiplicity
To determine whether atrial flutter is present, SMART Detection looks for a consistent N:1 pattern (e.g., 2:1, 3:1). An N:1 pattern, called Multiplicity, is confirmed when the average ventricular interval is found to be a multiple of the average atrial interval with a tolerance of ±12 ms to allow for minor normal variances. Multiplicity, like all SMART Detection criteria, is evaluated on a beat-to-beat basis (Fig. 20).
Dual-chamber AV discrimination algorithm (SMART)
SMART Detection is a very sophisticated detection algorithm for discrimination of VT and SVT. It is designed to increase the detection specificity (i. e., to increase the likelihood that atrial tachycardia is not declared a VT) without sacrificing sensitivity (i. e., the ability to detect and treat all clinical VTs of the patient). This can help to avoid inappropriate therapies. With SMART Detection, inappropriate shocks for SVT are minimized without compromising accurate VT detection and therapy.
Each time an interval is found to lie within one of the programmed VT zones, SMART Detection follows a series of decisions to determine whether the interval meets criteria for a VT count or an SVT count. VT criteria affect VT counters, while SVT intervals affect an SVT counter. VT intervals are labeled with VT1 or VT2 marker. SVT intervals are marked by one of four labels: AFib for atrial fibrillation, AFlut for atrial flutter, SinusT for sinus tachycardia, or 1:1 for atrial tachycardia.
Most tachyarrhythmias will occur when the ventricular rates are not equal to the atrial rates. Monomorphic VT without retrograde conduction, atrial flutter, and atrial fibrillation are identified by these portions of the decision tree (Fig. 21).
The SMART Detection algorithm is also available in a single lead BIOTRONIK ICD system. This so-called DX system consists of a single coil ICD lead with an active fixation mechanism and floating atrial ring electrodes for atrial IEGM recording. A dedicated atrial sensing amplifier with a special filter characteristic allows recording of an atrial signal, good enough to operate the SMART dual-chamber detection in a dedicated DX ICD.
VT counters with SMART Detection
When the VT criteria are met and the interval lies in the VT1 zone, the VT1 counter increments by one (the VT2 counter is unaffected). When the VT criteria are met and the interval lies in the VT2 zone, the VT2 and the VT1 counter increments by one (so called “combined counting”). VF intervals do not increase the VT counters.
SVT intervals decrement the VT counters: Atrial Flutter by one, Atrial Fibrillation by four, Sinus Tachycardia by ¼ for initial and redetection. In addition, 1:1 tachycardias decrement the VT counters by ¼ for initial and ¾ for redetection. An SVT is declared when the SVT criteria is met. The detection criteria for SVT is twice the VT zone count. For example, if the counter for a VT zone is programmed to 16 intervals, it will take 32 SVT intervals for an SVT episode to be declared (Fig. 22).
Detection of monomorphic/polymorphic VT
When a VT occurs without accompanying atrial tachyarrhythmia or without retrograde conduction AV discrimination is based on a comparison of rates alone—the ventricular rate is faster than the atrial rate. A monomorphic VT has a slow atrial rate, an accelerated ventricular rate, a stable QRS morphology, and stable R‑R intervals. Polymorphic VT has a slow atrial rate, an accelerated ventricular rate, a varying QRS morphology, and instable R‑R intervals. In both cases the single criterion ventricular rate faster than atrial rate will fulfill VT detection and subsequent therapy delivery (Fig. 21 , branch 1).
Discrimination of atrial flutter
Discrimination algorithms have difficulties to identify VT when it occurs in the presence of an ongoing atrial tachycardia. However, algorithms that carefully compare atrial and ventricular rates and their relation to each others are able to discriminate between SVT and VT without delay. When SMART Detection measures an interval in the VT zone and determines that the atrial rate is faster than the ventricular rate a double tachycardia is suspected. To classify the rhythm further, the algorithm looks at ventricular stability and multiplicity. A ventricular beat is classified as atrial flutter (AFlut marker) if the atrial rate is faster than the ventricular rate, the ventricular rate is stable, and an N:1 relationship exists between atrial and ventricular rates. The algorithm assumes that the accelerated ventricular rate results from atrial flutter with some degree of AV block. An AFlut interval will decrement the VT counter by one (Fig. 21 , branch 2).
Atrial tachycardia or atrial fibrillation with VT
A double tachycardia is identified along several branches of the SMART Detection decision tree. The double tachycardia in this section occurs when the atrial rate is faster than the ventricular rate, the ventricular rate is stable, but N:1 multiplicity cannot be established. When these conditions are met, a VT with concurrent atrial tachycardia or atrial fibrillation is identified. Each beat will be marked as VT (Fig. 21 , branch 3).
Atrial fibrillation
Atrial fibrillation is by nature irregular or chaotic with atrial intervals of varying duration. In turn, these atrial intervals are conducted irregularly to the ventricles. SMART Detection identifies irregular conduction and declares atrial fibrillation when the atrial rate is faster than the ventricular rate and the ventricular rate is unstable. Each ventricular interval is marked with an AFib marker. Therapy is withheld for this episode. An event declared as atrial fibrillation will decrease the VT counter by four to reduce the potential risk of delivering inappropriate therapy (Fig. 21 , branch 4).
VT with unstable atrial arrhythmia
Discrimination of VT is most difficult when atrial and ventricular rates are equal. Therefore, SMART Detection branches out to identify six different classification pathways when the atrial and ventricular rates are equal. When the algorithm identifies equal atrial and ventricular rates, the stability is tested in both chambers. If the ventricular rate is stable and the atrial rate is unstable, the algorithm concludes that the rhythms are dissociated. Therapy will be delivered for the VT (Fig. 21 , branch 5).
Concurrent atrial tachycardia with VT
When atrial and ventricular rates are similar and stable, several rhythms may exist. If successive AV intervals are present and strictly increase or decrease in duration (AV Trend), then one can deduce that the atrial and ventricular rhythms are close in rate, but dissociated. This small but consistent difference between the rates causes the AV interval to gradually shrink or expand over time (Fig. 21 , branch 6).
Distinguishing VT from sinus tachycardia
When atrial and ventricular rates are similar and stable with no AV trend, SMART Detection branches out to identify two different rhythms; monomorphic VT with 1:1 retrograde conduction and sinus tachycardia with 1:1 antegrade conduction. Monomorphic VT often starts rapidly with a significant rate increase occurring over three or four beats. In contrast, sinus tachycardia may develop over a longer time period such as during exercise. The sudden onset criterion is used to distinguish monomorphic VT with retrograde conduction from sinus tachycardia (Fig. 21 , branch 7 and 8). Intervals classified as Sinus Tachycardia are labeled with SinusT marker.
Polymorphic VT with retrograde conduction
Polymorphic VT can occur at higher rates than monomorphic VT. In addition, the QRS morphology and the heart rate can vary. When polymorphic VT is conducted back to the atrium on a beat-to-beat basis, instability is present in both chambers. Since the retrograde conduction is consistent and the intervals are unstable, the AV intervals become irregular. A polymorphic VT with retrograde conduction is detected when atrial and ventricular rates are equal, both chambers are unstable, and the AV interval is stable. Therapy is initiated to treat and terminate the polymorphic VT (Fig. 21 , branch 9).
Multifocal atrial tachycardia with antegrade conduction
If the atrial and ventricular rates are equal, both rhythms are unstable, but the AV intervals are regular, then a direct association between atrial and ventricular rhythms can be suggested. In other words, the rhythm originates in the atrium, and therefore the rhythm is irregular atrial tachycardia with 1:1 antegrade conduction. In this case, each beat is labeled with 1:1 marker, and therapy is appropriately withheld. An episode of atrial tachycardia is declared after twice the programmed VT count is met (Fig. 21 , branch 10).
SMART redetection
This is used after a VT therapy delivery to withhold further therapy if the delivered therapy resulted in an SVT. VT redetection is based on the programmable redetection count. The sustained VT timer is not utilized when SMART Redetection is ON.
Therapy reset
The purpose of Therapy Reset (also called Forced Termination) is to reset therapies after a successful termination of a VT that results in an SVT (e. g., permanent AFib). In this way, all programed therapies will be available should the arrhythmia revert back to a VT/VF. If an SVT occurs after successful termination of VT/VF and SMART Redetection is used, no therapy will be delivered for the SVT during redetection. If the SVT is still ongoing when the forced termination timer expires, the device will declare the end of the episode. The device will then record a new SVT episode if the SVT is still present and SVT EGM storage is ON.
Monitoring zone
In addition to programming therapies for VT zones, you may program a Monitoring Zone in the VT1 zone only. A monitoring zone cannot be programmed in the VT2 zone. The monitoring zone may be used to look for nonsustained VTs. Monitoring zones are programmed the same as standard VT1 zone programming except that therapies are not provided. Monitoring zone programs may also include the programming of SMART Detection as well to look for SVTs that may be previously known.
Conclusion
ICDs by BIOTRONIK provide a sophisticated sensing algorithm that can be flexibly adjusted in case of over- or undersensing situations during clinical troubleshooting. However, VF detection should be retested when sensing settings are reprogrammed. Classification of cardiac signals is accomplished primarily by measuring cardiac cycle length. These are ventricular intervals in single-chamber detection and ventricular, atrial and A–V intervals in dual-chamber detection. In addition, the ICD can also utilize abrupt changes in rate, irregularity of cycle lengths and other criteria as morphology to further differentiate tachyarrhythmias. To achieve best clinical results, the programming should be individualized after the occurrence of clinical episodes for each patient. Programming can be challenging in patients with atrial fibrillation and rapid ventricular response, slow VT that starts during exercise-induced sinus tachycardia, or onset of an AV nodal reentry tachycardia. Clinical studies demonstrated that the SMART Detection provided 100 % sensitivity and 89 % specificity [2].
References
http://web.hrsonline.org/Health-Policy/Clinical-Documents/Appendix-B-Manufacturer-Specific-Translation-of-Recommendations.pdf in relation to 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing. Publication Date: November 19, 2015
Sinha AM, Stellbrink C, Schuchert A, Möx B, Jordaens L, Lamaison D, Jaswinder G, Kaplan A, Merkely B (2004) Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol 15:646–652
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
T. Brüggemann, D. Dahlke, A. Chebbo and I. Neumann state that they have no competing interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s00399-016-0462-2.
Rights and permissions
Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden.
Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen.
Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf https://creativecommons.org/licenses/by/4.0/deed.de.
About this article
Cite this article
Brüggemann, T., Dahlke, D., Chebbo, A. et al. Tachycardia detection in modern implantable cardioverter–defibrillators. Herzschr Elektrophys 27, 171–185 (2016). https://doi.org/10.1007/s00399-016-0449-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00399-016-0449-z
Keywords
- BIOTRONIK
- Implantable cardioverter defibrillator
- Ventricular fibrillation
- Ventricular tachycardia
- Tachycardia discrimination
- Single-chamber detection
- Dual-chamber detection